Bronchiolitis Obliterans Syndrome (BOS) Completed Phase 2 Trials for Montelukast (DB00471)

Also known as: Bronchiolitis Obliterans (BO) / Bronchiolitis Obliterans / Obliterative Bronchiolitis / Bronchiolitis Obliterans Syndrome / Obliterating fibrous bronchiolitis (disorder) / Bronchiolitis fibrosa obliterans (disorder) / Obliterative bronchiolitis (disorder)

IndicationStatusPhase
DBCOND0071683 (Bronchiolitis Obliterans Syndrome (BOS))Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00656058Montelukast to Treat Bronchiolitis ObliteransTreatment
NCT01307462Targeted Therapy of Bronchiolitis Obliterans SyndromeTreatment